Elizabeth H. Weatherman
CIK: 0001188681
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 5, 2026RPRX
Royalty Pharma plc
Award(A)Direct4.5K shares- - Jun 3, 2026PODD
INSULET CORP
Purchase(P)Direct3.5K shares at avg. $144.20$497K - May 20, 2026PODD
INSULET CORP
Award(A)Direct1.7K shares- - Jul 31, 2025RPRX
Royalty Pharma plc
Award(A)Direct2.8K shares- - Jul 31, 2025RPRX
Royalty Pharma plc
Award(A)Direct5.8K shares- - May 22, 2025PODD
INSULET CORP
Award(A)Direct778 shares- - Apr 3, 2025NVRO
NEVRO CORP
Disposition(D)Direct86.2K shares- - Dec 31, 2024NVRO
NEVRO CORP
Award(A)Direct5.3K shares- - Sep 30, 2024NVRO
NEVRO CORP
Award(A)Direct3.5K shares- - Sep 20, 2024VAPO
VAPOTHERM INC
Disposition(D)Direct3K shares at avg. $2.18$7K - Sep 20, 2024VAPO
VAPOTHERM INC
Disposition(D)Indirect81.5K shares at avg. $2.18$178K - Sep 20, 2024VAPO
VAPOTHERM INC
Disposition(D)Direct14.6K shares at avg. $2.18$32K - Sep 17, 2024SILK
Silk Road Medical Inc
Disposition(D)Direct155K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 | RPRX Royalty Pharma plc | Award(A) | 4,545 | - | $0 | Direct |
| Jun 3, 2026 | PODD INSULET CORP | Purchase(P) | 3,450 | $144.20 | $497,490 | Direct |
| May 20, 2026 | PODD INSULET CORP | Award(A) | 1,660 | - | $0 | Direct |
| Jul 31, 2025 | RPRX Royalty Pharma plc | Award(A) | 2,752 | - | - | Direct |
| Jul 31, 2025 | RPRX Royalty Pharma plc | Award(A) | 5,806 | - | - | Direct |
| May 22, 2025 | PODD INSULET CORP | Award(A) | 778 | - | - | Direct |
| Apr 3, 2025 | NVRO NEVRO CORP | Disposition(D) | 86,171 | - | - | Direct |
| Dec 31, 2024 | NVRO NEVRO CORP | Award(A) | 5,325 | - | $0 | Direct |
| Sep 30, 2024 | NVRO NEVRO CORP | Award(A) | 3,544 | - | $0 | Direct |
| Sep 20, 2024 | VAPO VAPOTHERM INC | Disposition(D) | 3,000 | $2.18 | $6,540 | Direct |
| Sep 20, 2024 | VAPO VAPOTHERM INC | Disposition(D) | 81,546 | $2.18 | $177,770 | Indirect |
| Sep 20, 2024 | VAPO VAPOTHERM INC | Disposition(D) | 14,555 | $2.18 | $31,730 | Direct |
| Sep 17, 2024 | SILK Silk Road Medical Inc | Disposition(D) | 155,004 | - | $0 | Direct |
1-13 of 13 transactions
About WEATHERMAN ELIZABETH H
WEATHERMAN ELIZABETH H (SEC CIK 0001188681) files insider reports with the SEC as Director of Royalty Pharma plc (RPRX), Director of INSULET CORP (PODD) and Director of NEVRO CORP (NVRO). Signal8 also holds filings tied to 2 other companies.
Signal8 holds 11 ownership filings by WEATHERMAN ELIZABETH H (1 Form 3, 10 Form 4), filed between Sep 18, 2024 and Jun 8, 2026. Those filings report 13 transactions, from Sep 17, 2024 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on WEATHERMAN ELIZABETH H's filings is in ACTON, MA.
Recent filings by WEATHERMAN ELIZABETH H
- Jun 5, 2026: Grant or award of RPRX shares (Form 4, code A).
- Jun 3, 2026: Open-market purchase of PODD shares (Form 4, code P).
- May 20, 2026: Grant or award of PODD shares (Form 4, code A).
- Jul 31, 2025: Grants or awards of RPRX shares (2 lines, Form 4, code A).
- May 22, 2025: Grant or award of PODD shares (Form 4, code A).
Other insiders filing for Royalty Pharma plc (RPRX)
- Urist Marshall, EVP, Research & Investments
- Bassler Bonnie L, Director
- Hite Christopher, EVP & Chairman, Partnering
- Coyne Terrance P., EVP & CFO
- Legorreta Pablo G., CEO, Chairman of the Board
- Norden Gregory, Director